Award
University of Notre Dame du Lac 5R01EY036107-03
Selective Inhibition of GRP 94 to Treat Ocular Hypertension and Glaucoma
Recipient
University of Notre Dame
Award Amount
$591,767.00
Ceiling
$591,767.00
Awarded
July 27, 2026
Identifier
5R01EY036107-03
NIH grant awarded to University of Notre Dame for research on selective inhibition of GRP 94 to treat ocular hypertension and glaucoma, with a project period from 2024 to 2028 and an award amount of $591,767.
Description
This is a NIH grant opportunity for research on selective inhibitors of GRP 94 for glaucoma treatment, funded by the National Eye Institute. The project involves optimizing lead compounds, understanding mechanisms of action, and developing therapeutics for glaucoma and steroid-induced glaucoma.